Backstrom Jay T.

Backstrom Jay T. is listed in filings as Director at LAVA Therapeutics N.V.. This profile follows SEC Form 4 activity through Nov 17, 2025, including sale activity. Recent filings connect the profile to LAVA Therapeutics N.V. (LVTX), Agios Pharmaceuticals, Inc. - Common Stock (AGIO) (AGIO), and Scholar Rock Holding Corporation (SRRK). The current snapshot covers public activity from Jan 21, 2025 to Nov 17, 2025. Reported amounts are shown as $31.1K to $5.3M. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.